In Brief SU2C to spend $6 million on two trials in breast, prostate cancer September 20, 2019Vol.45 No.35
In Brief Broxmeyer receives Cord Blood Association’s Lifetime Achievement Award September 20, 2019Vol.45 No.35
In Brief Roswell Park gets $6.42 million DoD grant for immunotherapy platform September 20, 2019Vol.45 No.35
In Brief UCLA receives grant to develop immunotherapies for glioblastoma September 20, 2019Vol.45 No.35
Conversation with The Cancer Letter Fred Hutch’s Gilliland to step down in 2020 as part of what he sees as generational change September 20, 2019Vol.45 No.35By Paul Goldberg
Senate committee recommends $3 billion increase for NIH funding September 20, 2019Vol.45 No.35By Alexandria Carolan
FDA begins technology overhaul in preparation for tsunami of data and real-world evidence September 20, 2019Vol.45 No.35By Matthew Bin Han Ong
Guest Editorial Herceptin: What it took to make it happen September 20, 2019Vol.45 No.35By Robert Bazell
